Cervical Cancer & HPV Project
Cervical Cancer is one of the most common causes of cancer in Indian women. It is believed that in India there are 132,000 new cases every year, 74,000 women deaths every year with a women dying every 8 minutes from this disease. The majority of cervical cancers are caused by the HPV virus. In India access to HPV testing in needy populations is limited by cost of testing.
I-SHARE Foundation has received a CSR grant from Gharda Chemicals to enable free HPV testing for cervical cancer screening in populations that need it. I-SHARE has partnered with NGO Prayas to develop a comprehensive screening program. Women over the age of 30 (or over 25 years of age if they are HIV positive) undergo HPV testing free of cost under this program. Women who test positive, undergo counselling , appropriate treatments and further followup.
Our current grant should enable us to screen 3000 women, So far we have tested and screened over 1500 women in and around Pune city, We are soliciting donations and CSR collaborations to further expand the scope of this project and help save more lives.
How you can help:
CORPORATES: If you are interested in a CSR project collaboration, please get in touch. As an organisation run by doctors, we are committed to ensuring that the funds are utilised in scientifically proven ways to benefit lives. We will give you a detailed and timely update on the project progress and ensure a gratifying social impact.
NGOs: If you are currently working in the space of women's health, cervical cancer screening or related areas, we may be able to collaborate and expand the scope of our individual projects.
MEDICAL COLLEGE/ HOSPITALS: If you have patients that may benefit from HPV testing and are looking for abilities to fund the process, we invite you to look into our subsidised testing project below. We would also be open to designing a new project meeting the needs of your doctors and patients.
Subsidised Diagnostics Program
Subsidised Diagnostics Pogram
Our mission is to innovate solutions that improve healthcare access for underserved segments of the population especially women and children. Good healthcare starts with accurate diagnostics hence, one of I-SHARE Foundation’s areas of interest is in making
effective advanced diagnostics such as molecular genetic tests, affordable to all sections of society in a sustainable manner.
I-SHARE Foundation has received a CSR grant from Gharda Chemicals to enable subsidised testing for needy patients. Patients who need funding aid for diagnostic tests, fill out a subsidy request form and provide supporting documents substantiating need along with the physician's prescription. I-SHARE has partnered with Genepath DX to provide this testing at very low cost compared to MRP.
Following tests are being offered under the project :